ArticleBritish journal of cancer2012

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer.

N Steele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.